Follow
Sebastien Viatte
Sebastien Viatte
Arthritis Research UK Center for Genetics and Genomics, Centre for Musculoskeletal Research, The University of Manchester, UK
Verified email at manchester.ac.uk
Title
Cited by
Cited by
Year
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis
S Eyre, J Bowes, D Diogo, A Lee, A Barton, P Martin, A Zhernakova, ...
Nature genetics 44 (12), 1336-1340, 2012
7452012
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
JD Leuppi, P Schuetz, R Bingisser, M Bodmer, M Briel, T Drescher, ...
Jama 309 (21), 2223-2231, 2013
5522013
Genetics and epigenetics of rheumatoid arthritis
S Viatte, D Plant, S Raychaudhuri
Nature Reviews Rheumatology 9 (3), 141-153, 2013
4752013
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
G Palmer, D Talabot‐Ayer, C Lamacchia, D Toy, CA Seemayer, S Viatte, ...
Arthritis & rheumatism: official journal of the American College of …, 2009
3972009
Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway
JC Lee, M Espéli, CA Anderson, MA Linterman, JM Pocock, NJ Williams, ...
Cell 155 (1), 57-69, 2013
2592013
Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response
S Viatte, D Plant, B Han, B Fu, A Yarwood, W Thomson, DPM Symmons, ...
Jama 313 (16), 1645-1656, 2015
2002015
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors
DB Miklos, HT Kim, E Zorn, EP Hochberg, L Guo, A Mattes-Ritz, S Viatte, ...
Blood 103 (1), 353-359, 2004
1792004
Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients
S Viatte, D Plant, J Bowes, M Lunt, S Eyre, A Barton, J Worthington
Annals of the rheumatic diseases 71 (12), 1984-1990, 2012
1462012
Genetics of rheumatoid arthritis susceptibility, severity, and treatment response
S Viatte, A Barton
Seminars in immunopathology 39 (4), 395-408, 2017
1322017
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis
K Ishigaki, S Sakaue, C Terao, Y Luo, K Sonehara, K Yamaguchi, ...
Nature genetics 54 (11), 1640-1651, 2022
912022
Adalimumab in severe and acute sciatica: A multicenter, randomized, double‐blind, placebo‐controlled trial
S Genevay, S Viatte, A Finckh, P Zufferey, F Balagué, C Gabay
Arthritis & rheumatism 62 (8), 2339-2346, 2010
792010
Reverse immunology approach for the identification of CD8 T‐cell‐defined antigens: Advantages and hurdles
S Viatte, PM Alves, P Romero
Immunology and cell biology 84 (3), 318-330, 2006
722006
Brief Report: Identification of BACH2 and RAD51B as Rheumatoid Arthritis Susceptibility Loci in a Meta‐Analysis of Genome‐Wide Data
K McAllister, A Yarwood, J Bowes, G Orozco, S Viatte, D Diogo, ...
Arthritis & Rheumatism 65 (12), 3058-3062, 2013
56*2013
Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer
PMS Alves, N Lévy, BJ Stevenson, H Bouzourene, G Theiler, G Bricard, ...
Cancer immunity 8 (1), 11, 2008
542008
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
EMA Hensor, P McKeigue, SF Ling, M Colombo, JH Barrett, JL Nam, ...
Rheumatology 58 (8), 1400-1409, 2019
532019
Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome‐wide association study
G Orozco, S Viatte, J Bowes, P Martin, AG Wilson, AW Morgan, S Steer, ...
Arthritis & Rheumatology 66 (1), 24-30, 2014
522014
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer
PMS Alves, N Lévy, H Bouzourene, S Viatte, G Bricard, M Ayyoub, ...
Cancer Immunology, Immunotherapy 56, 839-847, 2007
522007
Replication of associations of genetic loci outside the HLA region with susceptibility to anti–cyclic citrullinated peptide–negative rheumatoid arthritis
S Viatte, J Massey, J Bowes, K Duffus, arcOGEN Consortium, S Eyre, ...
Arthritis & rheumatology 68 (7), 1603-1613, 2016
502016
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial
S Genevay, A Finckh, P Zufferey, S Viatte, F Balagué, C Gabay
Annals of the rheumatic diseases 71 (4), 560-562, 2012
502012
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
ML Burr, S Viatte, M Bukhari, D Plant, DP Symmons, W Thomson, ...
Arthritis research & therapy 14, 1-10, 2012
422012
The system can't perform the operation now. Try again later.
Articles 1–20